PAM
TEVA icon

Panagora Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Panagora Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Buy
18,763
+5,213
+38% +$174K ﹤0.01% 838
2026
Q1 		$408K Hold
13,550
– – ﹤0.01% 902
2025
Q4 		$423K Hold
13,550
– – ﹤0.01% 904
2025
Q3 		$274K Sell
13,550
-38,018
-74% -$668K ﹤0.01% 983
2025
Q2 		$864K Hold
51,568
– – ﹤0.01% 656
2025
Q1 		$793K Sell
51,568
-19,179
-27% -$343K ﹤0.01% 710
2024
Q4 		$1.56M Sell
70,747
-38,254
-35% -$696K 0.01% 567
2024
Q3 		$1.96M Sell
109,001
-16,269
-13% -$285K 0.01% 539
2024
Q2 		$2.04M Sell
125,270
-290,134
-70% -$4.47M 0.01% 518
2024
Q1 		$5.86M Sell
415,404
-81,798
-16% -$1.03M 0.03% 308
2023
Q4 		$5.19M Buy
497,202
+374,561
+305% +$3.5M 0.03% 311
2023
Q3 		$1.25M Sell
122,641
-42,650
-26% -$397K 0.01% 705
2023
Q2 		$1.24M Buy
165,291
+13,550
+9% +$110K 0.01% 712
2023
Q1 		$1.34M Sell
151,741
-81,048
-35% -$801K 0.01% 722
2022
Q4 		$2.12M Sell
232,789
-375,401
-62% -$3.28M 0.01% 612
2022
Q3 		$4.91M Sell
608,190
-717,473
-54% -$6.34M 0.03% 363
2022
Q2 		$9.97M Buy
1,325,663
+1,105,375
+502% +$9.63M 0.07% 252
2022
Q1 		$2.07M Buy
220,288
+124,578
+130% +$1.04M 0.01% 673
2021
Q4 		$767K Hold
95,710
– – ﹤0.01% 1044
2021
Q3 		$932K Sell
95,710
-1,570
-2% -$14.7K 0.01% 990
2021
Q2 		$963K Sell
97,280
-3,334
-3% -$35.3K 0.01% 1006
2021
Q1 		$1.16M Sell
100,614
-3,908
-4% -$44.8K 0.01% 958
2020
Q4 		$1.01M Sell
104,522
-76,183
-42% -$730K 0.01% 961
2020
Q3 		$1.63M Buy
180,705
+22,084
+14% +$234K 0.01% 729
2020
Q2 		$1.96M Sell
158,621
-22,206
-12% -$251K 0.01% 678
2020
Q1 		$1.62M Sell
180,827
-13,221
-7% -$135K 0.01% 666
2019
Q4 		$1.9M Sell
194,048
-47,068
-20% -$420K 0.01% 804
2019
Q3 		$1.66M Buy
241,116
+2,857
+1% +$21.9K 0.01% 822
2019
Q2 		$2.2M Sell
238,259
-730
-0.3% -$8.8K 0.01% 780
2019
Q1 		$3.75M Sell
238,989
-118,490
-33% -$2.09M 0.02% 602
2018
Q4 		$5.51M Sell
357,479
-45,405
-11% -$931K 0.03% 438
2018
Q3 		$8.68M Buy
402,884
+128,792
+47% +$2.99M 0.03% 388
2018
Q2 		$6.67M Sell
274,092
-17,328
-6% -$353K 0.03% 455
2018
Q1 		$4.98M Sell
291,420
-19,635
-6% -$383K 0.02% 537
2017
Q4 		$5.89M Buy
311,055
+261,658
+530% +$3.94M 0.02% 501
2017
Q3 		$869K Buy
49,397
+13,056
+36% +$294K ﹤0.01% 1175
2017
Q2 		$1.21M Sell
36,341
-54,815
-60% -$1.7M ﹤0.01% 1042
2017
Q1 		$2.92M Sell
91,156
-71,108
-44% -$2.43M 0.01% 739
2016
Q4 		$5.88M Sell
162,264
-133,508
-45% -$5.33M 0.03% 513
2016
Q3 		$13.6M Sell
295,772
-149,346
-34% -$7.79M 0.06% 296
2016
Q2 		$22.4M Sell
445,118
-257,362
-37% -$13.7M 0.11% 188
2016
Q1 		$37.6M Buy
702,480
+480,509
+216% +$28.2M 0.19% 120
2015
Q4 		$14.6M Buy
221,971
+4,418
+2% +$273K 0.07% 277
2015
Q3 		$12.3M Buy
217,553
+128,740
+145% +$8.35M 0.06% 300
2015
Q2 		$5.25M Buy
88,813
+9,632
+12% +$594K 0.03% 519
2015
Q1 		$4.93M Hold
79,181
– – 0.03% 503
2014
Q4 		$4.55M Buy
79,181
+14,499
+22% +$808K 0.02% 496
2014
Q3 		$3.48M Hold
64,682
– – 0.02% 591
2014
Q2 		$3.39M Hold
64,682
– – 0.02% 638
2014
Q1 		$3.42M Hold
64,682
– – 0.02% 671
2013
Q4 		$2.59M Sell
64,682
-102,444
-61% -$4.03M 0.01% 751
2013
Q3 		$6.31M Sell
167,126
-3,546
-2% -$138K 0.03% 445
2013
Q2 		$6.69M Buy
+170,672
New +$6.65M 0.03% 387

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Panagora Asset Management's TEVA Position: Q2 2026 in Review

Panagora Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 38% in Q2 2026, buying an estimated $174K and bringing the position to 18,763 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Panagora Asset Management first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $37.6M in Q1 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Panagora Asset Management held 18,763 shares of Teva Pharmaceuticals worth $636K as of Q2 2026.
  • Panagora Asset Management bought 5,213 Teva Pharmaceuticals shares in Q2 2026, an estimated $174K.
  • Teva Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #838 holding.
  • Panagora Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Panagora Asset Management's Teva Pharmaceuticals position peaked at $37.6M in Q1 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.